Prolyl hydroxylase inhibitors

摘要

The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I);
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.

主权项

1. A pharmaceutical composition for oral administration which comprises 1-700 mg of the compound:or a salt thereof and one or more pharmaceutically acceptable carriers, diluents or excipients.